136 related articles for article (PubMed ID: 12712436)
1. The role of RAD51 in etoposide (VP16) resistance in small cell lung cancer.
Hansen LT; Lundin C; Spang-Thomsen M; Petersen LN; Helleday T
Int J Cancer; 2003 Jul; 105(4):472-9. PubMed ID: 12712436
[TBL] [Abstract][Full Text] [Related]
2. DNA repair rate and etoposide (VP16) resistance of tumor cell subpopulations derived from a single human small cell lung cancer.
Hansen LT; Lundin C; Helleday T; Poulsen HS; Sørensen CS; Petersen LN; Spang-Thomsen M
Lung Cancer; 2003 May; 40(2):157-64. PubMed ID: 12711116
[TBL] [Abstract][Full Text] [Related]
3. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
[TBL] [Abstract][Full Text] [Related]
4. DNA breakage in human lung carcinoma cells and nuclei that are naturally sensitive or resistant to etoposide and teniposide.
Long BH; Musial ST; Brattain MG
Cancer Res; 1986 Aug; 46(8):3809-16. PubMed ID: 3015377
[TBL] [Abstract][Full Text] [Related]
5. In vitro evidence for homologous recombinational repair in resistance to melphalan.
Wang ZM; Chen ZP; Xu ZY; Christodoulopoulos G; Bello V; Mohr G; Aloyz R; Panasci LC
J Natl Cancer Inst; 2001 Oct; 93(19):1473-8. PubMed ID: 11584063
[TBL] [Abstract][Full Text] [Related]
6. Determinants of response to the DNA topoisomerase II inhibitors doxorubicin and etoposide in human lung cancer cell lines.
Kasahara K; Fujiwara Y; Sugimoto Y; Nishio K; Tamura T; Matsuda T; Saijo N
J Natl Cancer Inst; 1992 Jan; 84(2):113-8. PubMed ID: 1310509
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
Jain N; Lam YM; Pym J; Campling BG
Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
[TBL] [Abstract][Full Text] [Related]
8. Ku70 and Rad51 vary in their importance for the repair of doxorubicin- versus etoposide-induced DNA damage.
Schonn I; Hennesen J; Dartsch DC
Apoptosis; 2011 Apr; 16(4):359-69. PubMed ID: 21107697
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of human cancer xenografts as a tool for preclinical assessment: example of in-vivo evaluation of topotecan-based chemotherapy in a panel of human small-cell lung cancer xenografts.
Némati F; Daniel C; Arvelo F; Legrier ME; Froget B; Livartowski A; Assayag F; Bourgeois Y; Poupon MF; Decaudin D
Anticancer Drugs; 2010 Jan; 21(1):25-32. PubMed ID: 19823076
[TBL] [Abstract][Full Text] [Related]
10. Nonhomologous end-joining of ionizing radiation-induced DNA double-stranded breaks in human tumor cells deficient in BRCA1 or BRCA2.
Wang H; Zeng ZC; Bui TA; DiBiase SJ; Qin W; Xia F; Powell SN; Iliakis G
Cancer Res; 2001 Jan; 61(1):270-7. PubMed ID: 11196174
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of Rad51 participates in OTA-induced DNA double-strand breaks in GES-1 cells in vitro.
Lian H; Cui J; Wang Y; Liu J; Wang J; Shen H; Xing L; Wang J; Yan X; Zhang X
Toxicol Lett; 2014 Apr; 226(2):214-21. PubMed ID: 24525463
[TBL] [Abstract][Full Text] [Related]
12. DNA-dependent protein kinase stimulates an independently active, nonhomologous, end-joining apparatus.
DiBiase SJ; Zeng ZC; Chen R; Hyslop T; Curran WJ; Iliakis G
Cancer Res; 2000 Mar; 60(5):1245-53. PubMed ID: 10728683
[TBL] [Abstract][Full Text] [Related]
13. Identification of uPAR-positive chemoresistant cells in small cell lung cancer.
Gutova M; Najbauer J; Gevorgyan A; Metz MZ; Weng Y; Shih CC; Aboody KS
PLoS One; 2007 Feb; 2(2):e243. PubMed ID: 17327908
[TBL] [Abstract][Full Text] [Related]
14. RAD51 is involved in repair of damage associated with DNA replication in mammalian cells.
Lundin C; Schultz N; Arnaudeau C; Mohindra A; Hansen LT; Helleday T
J Mol Biol; 2003 May; 328(3):521-35. PubMed ID: 12706714
[TBL] [Abstract][Full Text] [Related]
15. The life and death of DNA-PK.
Collis SJ; DeWeese TL; Jeggo PA; Parker AR
Oncogene; 2005 Feb; 24(6):949-61. PubMed ID: 15592499
[TBL] [Abstract][Full Text] [Related]
16. In vitro chemo- and radio-resistance in small cell lung cancer correlates with cell adhesion and constitutive activation of AKT and MAP kinase pathways.
Kraus AC; Ferber I; Bachmann SO; Specht H; Wimmel A; Gross MW; Schlegel J; Suske G; Schuermann M
Oncogene; 2002 Dec; 21(57):8683-95. PubMed ID: 12483521
[TBL] [Abstract][Full Text] [Related]
17. Increased phosphorylation of DNA topoisomerase II in etoposide-resistant mutants of human cancer KB cells.
Takano H; Kohno K; Ono M; Uchida Y; Kuwano M
Cancer Res; 1991 Aug; 51(15):3951-7. PubMed ID: 1649696
[TBL] [Abstract][Full Text] [Related]
18. Selective inactivation of DNA-dependent protein kinase with antisense oligodeoxynucleotides: consequences for the rejoining of radiation-induced DNA double-strand breaks and radiosensitivity of human cancer cell lines.
Sak A; Stuschke M; Wurm R; Schroeder G; Sinn B; Wolf G; Budach V
Cancer Res; 2002 Nov; 62(22):6621-4. PubMed ID: 12438258
[TBL] [Abstract][Full Text] [Related]
19. Evidence of an adaptive response targeting DNA nonhomologous end joining and its transmission to bystander cells.
Klammer H; Kadhim M; Iliakis G
Cancer Res; 2010 Nov; 70(21):8498-506. PubMed ID: 20861183
[TBL] [Abstract][Full Text] [Related]
20. Comparison of DNA topoisomerase II alpha expression in small cell and nonsmall cell carcinoma of the lung. In search of a mechanism of chemotherapeutic response.
Guinee DG; Holden JA; Benfield JR; Woodward ML; Przygodzki RM; Fishback NF; Koss MN; Travis WD
Cancer; 1996 Aug; 78(4):729-35. PubMed ID: 8756364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
